Sacituzumab the Phase 3 TROPiCS-02 Trial Final OS Analysis in mBC Breast Cancer 3 Mins Read Sara Tolaney, MD, a renowned researcher from the Dana-Farber Cancer Institute, has recently conducted a groundbreaking study that has been…
